The Trump administration has declared that no federal funding can go toward supplies that “promote or facilitate drug use." ...

Houston Black Theatre Week returns October 19–26, 2025, at The DeLUXE Theater, celebrating Black creativity, storytelling, and community empowerment.

The refusal of blood transfusions by Jehovah’s Witnesses poses a major challenge in treating acute myeloid leukaemia (AML), ...

SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown strong ...

A major collaboration between UC San Diego and 23andMe identified genes that shape cannabis use behaviors. The study linked the CADM2 and GRM3 genes to cannabis use and connected these patterns to ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

The US Food and Drug Administration granted 510(k) marketing clearances for various tests to aid the diagnosis and treatment of infectious diseases, among other products.

This event is part of the U.S. DEA National Prescription Drug Take Back Day, a nationwide effort to reduce the risks linked to unused or expired medications.

KEYTRUDA is indicated for the treatment of patients with resectable (tumors ≥4 cm or node positive) NSCLC in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then ...